Ensign Peak Advisors Inc reduced its stake in shares of DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 2.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 958,344 shares of the basic materials company's stock after selling 20,791 shares during the quarter. Ensign Peak Advisors Inc owned about 0.23% of DuPont de Nemours worth $73,074,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the stock. Choreo LLC boosted its position in shares of DuPont de Nemours by 23.4% during the fourth quarter. Choreo LLC now owns 43,307 shares of the basic materials company's stock valued at $3,296,000 after buying an additional 8,205 shares during the period. Merit Financial Group LLC grew its stake in DuPont de Nemours by 36.4% during the 4th quarter. Merit Financial Group LLC now owns 18,496 shares of the basic materials company's stock worth $1,410,000 after buying an additional 4,939 shares during the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in DuPont de Nemours during the 4th quarter valued at about $1,343,000. Grandfield & Dodd LLC increased its position in DuPont de Nemours by 72.0% during the 4th quarter. Grandfield & Dodd LLC now owns 7,538 shares of the basic materials company's stock valued at $575,000 after buying an additional 3,155 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of DuPont de Nemours by 3.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,868,586 shares of the basic materials company's stock valued at $218,730,000 after acquiring an additional 91,108 shares during the period. 73.96% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on the company. JPMorgan Chase & Co. cut their price target on DuPont de Nemours from $101.00 to $76.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 8th. Barclays decreased their price target on shares of DuPont de Nemours from $89.00 to $73.00 and set an "equal weight" rating on the stock in a research note on Tuesday, April 29th. Wells Fargo & Company decreased their price target on shares of DuPont de Nemours from $105.00 to $81.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 9th. Wolfe Research raised shares of DuPont de Nemours from a "peer perform" rating to an "outperform" rating and set a $91.00 target price on the stock in a research note on Friday, January 17th. Finally, Morgan Stanley cut their price target on shares of DuPont de Nemours from $94.00 to $80.00 and set an "equal weight" rating for the company in a report on Monday, May 5th. Four analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $85.07.
Check Out Our Latest Research Report on DuPont de Nemours
DuPont de Nemours Stock Up 6.8%
DD stock traded up $4.54 during midday trading on Monday, hitting $71.31. The company's stock had a trading volume of 5,769,777 shares, compared to its average volume of 2,430,657. The company has a quick ratio of 0.88, a current ratio of 1.33 and a debt-to-equity ratio of 0.22. DuPont de Nemours, Inc. has a 52-week low of $53.77 and a 52-week high of $90.06. The firm has a market capitalization of $29.84 billion, a P/E ratio of 42.70, a PEG ratio of 2.15 and a beta of 1.07. The firm has a 50-day simple moving average of $68.20 and a 200-day simple moving average of $75.84.
DuPont de Nemours (NYSE:DD - Get Free Report) last released its quarterly earnings data on Friday, May 2nd. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.08. The business had revenue of $3.07 billion during the quarter, compared to analysts' expectations of $3.05 billion. DuPont de Nemours had a net margin of 5.47% and a return on equity of 7.12%. The company's revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.79 EPS. As a group, equities analysts forecast that DuPont de Nemours, Inc. will post 4.38 EPS for the current year.
DuPont de Nemours Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Friday, May 30th will be given a $0.41 dividend. The ex-dividend date of this dividend is Friday, May 30th. This represents a $1.64 dividend on an annualized basis and a yield of 2.30%. DuPont de Nemours's dividend payout ratio (DPR) is presently -863.16%.
DuPont de Nemours Company Profile
(
Free Report)
DuPont de Nemours, Inc provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits.
See Also

Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.